Market Closed -
Oslo Bors
10:45:00 2024-04-23 am EDT
5-day change
1st Jan Change
191.6
NOK
+0.10%
-0.10%
+11.79%
Borregaard : Quarterly and accounting figures 4th quarter 2022 (xlsx)
February 02, 2023 at 03:40 am EST
Income Statement
Income Statement Borregaard Group Q4 2022
1.10-31.12
1.1-31.12
Amounts in NOK million
2022
2021
2022
2021
Operating revenues
1,770
1,446
6,881
5,805
Operating expenses
-1,406
-1,183
-5,238
-4,433
EBITDA
364
263
1,643
1,372
Depreciation property, plant and equipment
-114
-106
-444
-416
Amortisation intangible assets
-2
-1
-5
-4
Other income and expenses
-20
0
-8
0
Operating profit
228
156
1,186
952
Financial items, net
-18
-24
-68
-79
Profit before taxes
210
132
1,118
873
Income tax expence
-47
-39
-267
-213
Profit for the period
163
93
851
660
Profit attributable to non-controlling interests
-21
-9
-41
-32
Profit attributable to owners of the parent
184
102
892
692
Earnings per share (NOK)
1.85
1.02
8.95
6.95
EBITDA margin
20.6 %
18.2 %
23.9 %
23.6 %
Balance Sheet
Interim condensed statement of financial position Borregaard Group
31/12/
30/9/
31/12/
Amounts in NOK million
2022
2022
2021
Assets:
Intangible assets
82
84
89
Property, plant and equipment
4,371
4,339
4,191
Right-of-use assets
345
342
351
Other assets
254
240
339
Investments in joint venture/associate company
142
143
173
Non-current assets
5,194
5,148
5,143
Inventories
1,299
1,230
792
Receivables
1,387
1,495
1,107
Cash and cash deposits
234
167
124
Current assets
2,920
2,892
2,023
Total assets
8,114
8,040
7,166
Equity and debt:
Group equity
4,394
3,929
4,222
Non-controlling interests
51
79
84
Equity
4,445
4,008
4,306
Provisions and other liabilities
295
438
257
Interest-bearing liabilities
1,370
1,523
1,320
Non-current liabilities
1,665
1,961
1,577
Interest-bearing liabilities
702
641
224
Other current liabilities
1,302
1,430
1,059
Current liabilities
2,004
2,071
1,283
Equity and liabilities
8,114
8,040
7,166
Equity ratio (%):
54.8 %
49.9 %
60.1 %
Cashflow
Interim condensed cash flow statement Borregaard Group Q4 2022
1.10-31.12
1.1-31.12
Amounts in NOK million
2022
2021
2022
2021
Profit before taxes
210
132
1,118
873
Amortisation, depreciation and impairment charges
116
107
449
420
Change in net working capital, etc
55
174
-658
256
Dividend/share of profit from JV & associate company
3
6
34
6
Taxes paid
-71
-63
-208
-124
Cash flow from operating activities
313
356
735
1,431
Investments property, plant and equipment and intangible assets *
-212
-227
-464
-556
Investment in associate company
0
-35
0
-145
Other capital transactions
4
4
9
9
Cash flow from Investing activities
-208
-258
-455
-692
Dividends
0
0
-499
-249
Proceeds from exercise of options/shares to employees
7
4
41
59
Buy-back of shares
-45
-7
-68
-118
Gain/(loss) on hedges for net investments in subsidiaries
77
-25
-79
-14
Net paid to/from shareholders
39
-28
-605
-322
Proceeds from interest-bearing liabilities
0
0
837
300
Repayment of interest-bearing liabilities
-43
-146
-512
-814
Change in interest-bearing receivables/other liabilities
-41
4
78
-1
Change in net interest-bearing liablities
-84
-142
403
-515
Cash flow from financing activities
-45
-170
-202
-837
Change in cash and cash equivalents
60
-72
78
-98
Cash and cash equivalents at beginning of period
76
76
5
96
Change in cash and cash equivalents
60
-72
78
-98
Currency effects cash and cash equivalents
-25
1
28
7
Cash and cash equivalents at the end of the period
111
5
111
5
* Investment by category:
Replacement investments
172
190
359
398
Expansion investments including investment in associate company
40
72
105
303
Total investments including investment in associate company
212
262
464
701
Segment
Quarterly segment information Borregaard Group
Operating revenues
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
4,785
5,063
1,372
1,358
1,260
1,338
5,328
1,419
1,511
1,429
1,446
5,805
1,615
1,744
1,752
1,770
6,881
BioSolutions
2,775
2,982
797
819
733
733
3,082
812
885
838
934
3,469
948
1,098
1,007
997
4,050
BioMaterials
1,661
1,712
454
417
403
458
1,732
523
482
468
405
1,878
532
540
558
620
2,250
Fine Chemicals
374
406
128
131
131
153
543
90
155
132
114
491
143
119
200
170
632
Eliminations
-25
-37
-7
-9
-7
-6
-29
-6
-11
-9
-7
-33
-8
-13
-13
-17
-51
EBITDA
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
903
1 007
242
361
266
263
1 132
302
416
391
263
1,372
400
445
434
364
1,643
BioSolutions
499
647
170
193
132
137
632
205
272
251
214
942
261
305
261
159
986
BioMaterials
312
234
46
101
91
80
318
64
102
91
27
284
97
91
101
138
427
Fine Chemicals
92
126
26
67
43
46
182
33
42
49
22
146
42
49
72
67
230
Depreciations and write downs
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
-323
-418
-109
-112
-112
-110
-443
-106
-101
-103
-106
-416
-108
-110
-112
-114
-444
BioSolutions
-113
-183
-51
-51
-53
-51
-206
-48
-45
-47
-49
-189
-50
-53
-54
-55
-212
BioMaterials
-189
-203
-50
-52
-51
-50
-203
-50
-47
-47
-49
-193
-49
-48
-49
-49
-195
Fine Chemicals
-21
-32
-8
-9
-8
-9
-34
-8
-9
-9
-8
-34
-9
-9
-9
-10
-37
Amortisation
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
-4
-4
-1
-1
-1
-2
-5
-1
-1
-1
-1
-4
-1
-1
-1
-2
-5
BioSolutions
-4
-4
-1
-1
-1
-2
-5
-1
-1
-1
-1
-4
-1
-1
-1
-2
-5
BioMaterials
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Fine Chemicals
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other income and expenses
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
0
-27
0
-96
0
-20
-116
0
0
0
0
0
0
12
0
-20
-8
BioSolutions
0
-16
0
-90
0
-7
-97
0
0
0
0
0
0
12
0
-6
6
BioMaterials
0
-11
0
-6
0
-12
-18
0
0
0
0
0
0
0
0
-12
-12
Fine Chemicals
0
0
0
0
0
-1
-1
0
0
0
0
0
0
0
0
-2
-2
Operating profit (EBIT)
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
576
558
132
152
153
131
568
195
314
287
156
952
291
346
321
228
1,186
BioSolutions
382
444
118
51
78
77
324
156
226
203
164
749
210
263
206
96
775
BioMaterials
123
20
-4
43
40
18
97
14
55
44
-22
91
48
43
52
77
220
Fine Chemicals
71
94
18
58
35
36
147
25
33
40
14
112
33
40
63
55
191
Hedging effects & currency exposure
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard - EBITDA hedging gains & losses
-11
-76
-62
-84
-51
-44
-241
-15
-4
-16
6
-29
10
-3
-23
-34
-50
BioSolutions
3
-33
-26
-38
-21
-18
-103
-5
-1
-6
1
-11
3
-5
-19
-23
-44
BioMaterials
-3
-37
-30
-39
-25
-22
-116
-8
-3
-8
4
-15
5
1
-4
-9
-7
Fine Chemicals
-11
-6
-6
-7
-5
-4
-22
-2
0
-2
1
-3
2
1
0
-2
1
Borregaard - USD EBITDA currency exposure (approx)
194
203
177
198
197
Borregaard - EUR EBITDA currency exposure (approx)
84
98
112
139
147
Sales revenues
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
Amounts in NOK million
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Borregaard
4 705
4 951
1 347
1 337
1 229
1 314
5 227
1,394
1,491
1,406
1,424
5,715
1,591
1,720
1,723
1,742
6,776
BioSolutions
2 708
2 873
775
800
706
714
2 995
793
865
819
915
3,392
929
1,072
979
966
3,946
BioMaterials
1 630
1 679
445
407
395
448
1 695
513
472
457
398
1,840
521
530
546
608
2,205
Fine Chemicals
369
400
127
130
128
153
538
88
154
131
112
485
141
118
198
168
625
Eliminations
-2
-1
0
0
0
-1
-1
0
0
-1
-1
-2
0
0
0
0
0
BioSolutions
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Average gross sales price NOK per mtds
5 654
6 166
6 885
7 431
6 701
6 756
6 951
7,838
7,709
7,761
9,244
8,106
9,780
10,150
10,479
11,104
10,369
Volume (`000 mtds)
468
470
115
106
99
96
416
90
100
92
84
366
81
90
84
79
334
Specialities volume (`000 mtds)
86
86
88
89
84
Contruction volume (`000 mtds)
212
209
178
131
117
Industrial volume (`000 mtds)
170
175
150
146
133
BioMaterials
1.1-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
1.1-31.3
1.4-30.6
1.7-30.9
1.10-31.12
1.1-31.12
2018
2019
2020
2020
2020
2020
2020
2021
2021
2021
2021
2021
2022
2022
2022
2022
2022
Average gross sales price NOK per mt
10 337
10 665
11 382
12 579
11 780
11 128
11 678
10 641
10 754
10 972
10 911
10 807
12 595
13 656
14 880
16 179
14 283
Volume (`000 mt)
150.1
153.1
40.0
33.9
34.2
40.3
148.4
47.5
42.4
40.2
34.3
164.4
39.4
36.6
34.7
36.3
147.0
High specialised as % of total cellulose product sales volum
62%
73%
77%
79%
85%
Attachments
Original Link
Original Document
Permalink
Disclaimer
Borregaard ASA published this content on 02 February 2023 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 02 February 2023 08:39:09 UTC .
Borregaard to Issue NOK300 Million Commercial Paper
Apr. 17
MT
Nordic Stocks Declined Friday; Bravida Holding Took Biggest Hit
Apr. 05
DJ
Borregaard ASA Reports Earnings Results for the Full Year Ended December 31, 2023
Jan. 31
CI
Tranche Update on Borregaard ASA (OB:BRG)'s Equity Buyback Plan announced on November 28, 2023.
Jan. 31
CI
Borregaard ASA Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Jan. 31
CI
Transcript : Borregaard ASA, Q4 2023 Earnings Call, Jan 31, 2024
Jan. 31
Borregaard ASA Proposes Cash Dividend for 2023, Payable on 22 April 2024
Jan. 31
CI
Kaffe Bueno ApS announced that it expects to receive ?6.2 million in funding from Borregaard ASA, European Innovation Council Fund and other investors
Dec. 21
CI
Nordic Stocks Moved Upward Monday; Schibsted Led Increases
Dec. 11
DJ
Lignovations announced that it has received ?2.2 million in funding from Borregaard ASA, Valnon Holding GmbH and other investors
Dec. 03
CI
Borregaard ASA (OB:BRG) commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved from April 18, 2023.
Nov. 28
CI
Norwegian Biochemicals Group Borregaard Plans Share Buyback
Nov. 17
MT
Borregaard ASA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
23-10-24
CI
Transcript : Borregaard ASA, Q3 2023 Earnings Call, Oct 24, 2023
23-10-24
Borregaard Inks New Power Purchase Deal with Å Energi
23-10-18
MT
Borregaard ASA and A Energi Enter into New Long-Term Power Purchase Agreement for the Period 2024 to 2033
23-10-18
CI
Nordic Shares Closed Up Thursday; Truecaller Series B Topped Leaders
23-09-07
DJ
Transcript : Borregaard ASA, Q2 2023 Earnings Call, Jul 18, 2023
23-07-18
Borregaard ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
23-07-17
CI
Borregaard ASA Reports Earnings Results for the First Quarter Ended March 31, 2023
23-05-03
CI
Transcript : Borregaard ASA, Q1 2023 Earnings Call, May 03, 2023
23-05-03
Tranche Update on Borregaard ASA (OB:BRG)'s Equity Buyback Plan announced on April 7, 2022.
23-05-02
CI
Borregaard to Issue NOK300 Million Commercial Paper
23-04-20
MT
Transcript : Borregaard ASA - Shareholder/Analyst Call
23-04-18
Borregaard ASA's Equity Buyback announced on April 7, 2022, has expired.
23-04-17
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Borregaard ASA is a Norway-based biorafinery. The Group provides sustainable products and solutions based on renewable raw materials. Its business model is closely linked to the integrated nature of its biorefinery in Norway, which utilises the three key components of wood cellulose fibres, lignin and sugars to produce a diversified portfolio of products. The Company operates through three business segments. BioSolutions develops, produces and sells biopolymers and biovanillin from lignin. BioMaterials develops, produces and sells speciality cellulose mainly for use as a raw material in the production of cellulose ethers, cellulose acetate and other speciality products. Fine Chemicals consists of second-generation bioethanol and intermediates mainly for contrast agents.
More about the company
Last Close Price
191.6
NOK
Average target price
201.5
NOK
Spread / Average Target
+5.17%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1